« Return to News | CROs/Service Providers

MDS Appoints New CEO, Announces Changes to Executive Team

Friday, January 8, 2010 09:50 AM

MDS has appointed chief operating officer Steve West as CEO, replacing Stephen DeFalco.

West is president of MDS Nordion, which became MDS’ primary business unit after the company launched a strategic repositioning effort last summer.  

The Toronto-based company sold MDS Analytical Technologies and its late-stage contract research business in 2009 and has been seeking a buyer for its early-stage contract research unit, MDS Pharma Services, for several months. MDS Nordion will become MDS’ premier business line once a suitable buyer is found.

The company also announced that Peter Dans, MDS Nordion’s senior vice president, finance, will become the company’s chief financial officer (CFO) February 1. Current executive vice president and CFO Doug Prince plans to leave MDS March 1.

"With the strategic repositioning of MDS under way, the board believes it is appropriate to move forward with its CEO transition plan," said James MacDonald, chairman of MDS' board of directors, in a company statement. "We are confident that Steve's attention to financial performance and his track record of strengthening operations will serve the company well, both now and into the future.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.